Clinical Trials Browser

OTHER_GOV × Carcinoma, Non-Small-Cell Lung × Erlotinib Hydrochloride × Clear all

NCT01470716 2022-04-06

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis